News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY) Begins Tender Offer to Acquire KOSAN Biosciences, Inc. (KOSN)



5/30/2008 10:46:52 AM

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) is commencing today, through its wholly owned subsidiary KB Acquisition Corp., a cash tender offer to purchase all outstanding shares of common stock of Kosan Biosciences Inc. (NASDAQ: KOSN). Bristol-Myers Squibb reported earlier today its intent to acquire Kosan.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES